Novel transcript antisense to aristaless-like homeobox 3 (ENSG00000258634)

This molecule is a novel, noncoding RNA transcript mapped antisense to the **aristaless-like homeobox 3 (ALX3)** locus, designated as ENSG00000258634. Antisense transcripts naturally occur across many gene loci and can modulate gene expression of their sense counterpart through mechanisms such as RNA masking (formation of duplexes), regulation of splicing, chromatin modification, and transcript stability[4][1]. For ALX3—which encodes a transcription factor crucial for craniofacial and nasal development[3][2]—the presence of an antisense transcript might influence the amount, processing, or stability of ALX3 mRNA. However, direct experimental studies of this specific transcript's effect on ALX3 or its biological role are lacking. It is not recognized as a receptor, enzyme, or therapeutic target, and is not associated with any known drug interactions, biomarkers, or safety risks. If you require information for a canonical druggable target, ALX3 itself (aristaless-like homeobox 3) is a transcription factor with developmental roles, notably in craniofacial morphogenesis; its mutations cause frontonasal dysplasia, but as a transcription factor, it is not considered a classic drug target[3][2].

Other names

antisense to ALX3ENSG00000258634ALX3 antisense transcriptnovel transcript antisense to ALX3